Virtual Reliability System for Visual Spatial Attention Evaluation in Stroke Patients

Sponsor
National Taiwan University Hospital (Other)
Overall Status
Enrolling by invitation
CT.gov ID
NCT05332964
Collaborator
(none)
200
1
16.2
12.3

Study Details

Study Description

Brief Summary

The researchers designed a software based on a head-mounted displays for virtual reality (HMD-VR) to evaluate the reaction time to stimuli presented at right or left visual field. The study will recruit 100 stroke patients with hemisphere lesions (50 patients for right and left each) and 100 age-matched healthy controls. The participants will conduct a simple reaction time task in VR, with stimuli designated in the left or right hemi-field. The stroke patients will also received traditional tests for hemi-neglect. Test-retest reliability of the assessment will be conducted in a subset of the control group. The stroke patients will be followed in 3-4 weeks.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    The researchers designed a software based on a head-mounted displays for virtual reality (HMD-VR) to evaluate the reaction time to stimuli presented at right or left visual field. The study will recruit 100 stroke patients with hemisphere lesions (50 patients for right and left hemisphere each) and 100 age-matched healthy controls. The participants will conduct a simple reaction time task in VR, with stimuli designated in the left or right hemi-field. The stroke patients will also receive traditional tests for hemi-neglect. The researchers will also collect the demographic data, cognition function and daily activity function. Test-retest reliability of the assessment will be conducted in a subset of the control group. The stroke patients will be followed in 3-4 weeks. The researchers will compare the results of a traditional hemi-neglect tests and VR-based tests and their changes in two occasions.

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    200 participants
    Observational Model:
    Case-Control
    Time Perspective:
    Prospective
    Official Title:
    Application of a Virtual Reliability System in the Evaluation of the Visual Spatial Attention in Stroke Patients
    Actual Study Start Date :
    Aug 24, 2021
    Anticipated Primary Completion Date :
    Dec 31, 2022
    Anticipated Study Completion Date :
    Dec 31, 2022

    Arms and Interventions

    Arm Intervention/Treatment
    stroke (right)

    stroke patient with lesions at right hemisphere

    stroke (left)

    stroke patient with lesions at left hemisphere

    control

    age-matched group for the stroke patients

    Outcome Measures

    Primary Outcome Measures

    1. reaction time [4 weeks]

      reaction time to the stimuli presented in the right or left hemi-field with VR software

    2. hemineglect tests [4 weeks]

      Paper-based behavior inattention test (BIT)

    Secondary Outcome Measures

    1. ADL [4 weeks]

      activities of daily living function evaluated by barthel index

    2. cognition [4 weeks]

      using Montreal Cognitive Assessment (MoCA)

    3. cybersickness [1 day]

      using Simulator Sickness Questionnaire (SSQ)

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    20 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria for stroke patients:
    1. aged at least 20 years old

    2. diagnosed with stroke involving unilateral MCA and ACA territory

    3. with unilateral upper limb with normal function

    4. neurologically and medically stable.

    Inclusion criteria for control group:
    1. healthy adults, age-matched to stroke patients
    Exclusion Criteria for both groups:
    1. with history of neurological or psychiatric conditions other than stroke;

    2. significant cognitive or speech problems that cause difficulties to cooperate with testing;

    3. significant visual problems (such as color blindness, visual loss, cataract, glaucoma or other major eye condition)

    4. upper limb musculoskeletal disorders to cause difficulties to use the keyboard or controller;

    5. history of seizure, vestibular dysfunction or vertigo

    6. can't tolerate HMD-VR

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 National Taiwan University Hospital Taipei Taiwan

    Sponsors and Collaborators

    • National Taiwan University Hospital

    Investigators

    • Principal Investigator: Huey-Wen Liang, MD, National Taiwan University

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    National Taiwan University Hospital
    ClinicalTrials.gov Identifier:
    NCT05332964
    Other Study ID Numbers:
    • 202104030RINC
    First Posted:
    Apr 18, 2022
    Last Update Posted:
    Apr 18, 2022
    Last Verified:
    Apr 1, 2022
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by National Taiwan University Hospital
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Apr 18, 2022